Article Type
Article
Changed
Tue, 05/03/2022 - 15:59
Display Headline
Evidence-Based Management of Diabetic Dyslipidemia in a VA Population: Beyond the LDL Target
Author(s)
Gu W
Mallios R
Baylor P
Cohen A
Pall V
Huang J.

Article PDF
028060024.pdf
Author and Disclosure Information

Wei Gu, MD; Ronna Mallios, PhD; Peter Baylor, MD; Alan Cohen, MD; Vishal Pall, MD; and Jian Huang, MD.

Dr. Gu is a staff physician in the Department of Primary Care; Drs. Baylor, Pall, and Huang are staff physicians; and Dr. Cohen is associate chief of staff for ambulatory care, all at the Roseburg VA Medical Center in Oregon. Dr. Mallios is a biostatistician in the University of California, San Francisco (UCSF) Fresno Medical Education Program. In addition, Drs. Gu, Cohen, and Pall are clinical assistant professors, and Drs. Baylor and Huang are clinical associate professors, all in the UCSF Fresno Medical Education Program.

Issue
Federal Practitioner - 28(6)
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Topics
Diabetes
Page Number
24
Legacy Keywords
diabetic dyslipidemia, low-density lipoprotein, LDL, metabolic derangements, type 2 diabetes, cardiovascular complications, cardiovascular disease, CVD, high-density lipoprotein, HDL, triglyceride, TG, Framingham heart, lipoprotein abnormalities, atherogenic LDL particle, TG-rich lipoproteins, TGRLPs, atherosclerotic vascular disease, residue risk, very low-density lipoproteins, VLDLs, intermediate-density lipoproteins, IDLs, pathogenesis, atherosclerosis, hypertriglyceridemia, National Cholesterol Education Program Adult Treatment Panel III, NCEP ATP III, apolipoprotein B, apoB, vascular inflammation, hypertriglyceridemia, type 2 diabetes, VA Central California Health Care System, VACCHCS, International Classification of Diseases, Bachman Synchron LX 200 Analyzer, VA Northern California Institutional Review Board, McNemar's test diabetic dyslipidemia, low-density lipoprotein, LDL, metabolic derangements, type 2 diabetes, cardiovascular complications, cardiovascular disease, CVD, high-density lipoprotein, HDL, triglyceride, TG, Framingham heart, lipoprotein abnormalities, atherogenic LDL particle, TG-rich lipoproteins, TGRLPs, atherosclerotic vascular disease, residue risk, very low-density lipoproteins, VLDLs, intermediate-density lipoproteins, IDLs, pathogenesis, atherosclerosis, hypertriglyceridemia, National Cholesterol Education Program Adult Treatment Panel III, NCEP ATP III, apolipoprotein B, apoB, vascular inflammation, hypertriglyceridemia, type 2 diabetes, VA Central California Health Care System, VACCHCS, International Classification of Diseases, Bachman Synchron LX 200 Analyzer, VA Northern California Institutional Review Board, McNemar's test
Sections
Clinical Review
Author(s)
Gu W
Mallios R
Baylor P
Cohen A
Pall V
Huang J.
Author(s)
Gu W
Mallios R
Baylor P
Cohen A
Pall V
Huang J.
Author and Disclosure Information

Wei Gu, MD; Ronna Mallios, PhD; Peter Baylor, MD; Alan Cohen, MD; Vishal Pall, MD; and Jian Huang, MD.

Dr. Gu is a staff physician in the Department of Primary Care; Drs. Baylor, Pall, and Huang are staff physicians; and Dr. Cohen is associate chief of staff for ambulatory care, all at the Roseburg VA Medical Center in Oregon. Dr. Mallios is a biostatistician in the University of California, San Francisco (UCSF) Fresno Medical Education Program. In addition, Drs. Gu, Cohen, and Pall are clinical assistant professors, and Drs. Baylor and Huang are clinical associate professors, all in the UCSF Fresno Medical Education Program.

Author and Disclosure Information

Wei Gu, MD; Ronna Mallios, PhD; Peter Baylor, MD; Alan Cohen, MD; Vishal Pall, MD; and Jian Huang, MD.

Dr. Gu is a staff physician in the Department of Primary Care; Drs. Baylor, Pall, and Huang are staff physicians; and Dr. Cohen is associate chief of staff for ambulatory care, all at the Roseburg VA Medical Center in Oregon. Dr. Mallios is a biostatistician in the University of California, San Francisco (UCSF) Fresno Medical Education Program. In addition, Drs. Gu, Cohen, and Pall are clinical assistant professors, and Drs. Baylor and Huang are clinical associate professors, all in the UCSF Fresno Medical Education Program.

Article PDF
028060024.pdf
Article PDF
028060024.pdf

Issue
Federal Practitioner - 28(6)
Issue
Federal Practitioner - 28(6)
Page Number
24
Page Number
24
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Publications
Federal Practitioner
Type 2 Diabetes ICYMI
Topics
Diabetes
Article Type
Article
Display Headline
Evidence-Based Management of Diabetic Dyslipidemia in a VA Population: Beyond the LDL Target
Display Headline
Evidence-Based Management of Diabetic Dyslipidemia in a VA Population: Beyond the LDL Target
Legacy Keywords
diabetic dyslipidemia, low-density lipoprotein, LDL, metabolic derangements, type 2 diabetes, cardiovascular complications, cardiovascular disease, CVD, high-density lipoprotein, HDL, triglyceride, TG, Framingham heart, lipoprotein abnormalities, atherogenic LDL particle, TG-rich lipoproteins, TGRLPs, atherosclerotic vascular disease, residue risk, very low-density lipoproteins, VLDLs, intermediate-density lipoproteins, IDLs, pathogenesis, atherosclerosis, hypertriglyceridemia, National Cholesterol Education Program Adult Treatment Panel III, NCEP ATP III, apolipoprotein B, apoB, vascular inflammation, hypertriglyceridemia, type 2 diabetes, VA Central California Health Care System, VACCHCS, International Classification of Diseases, Bachman Synchron LX 200 Analyzer, VA Northern California Institutional Review Board, McNemar's test diabetic dyslipidemia, low-density lipoprotein, LDL, metabolic derangements, type 2 diabetes, cardiovascular complications, cardiovascular disease, CVD, high-density lipoprotein, HDL, triglyceride, TG, Framingham heart, lipoprotein abnormalities, atherogenic LDL particle, TG-rich lipoproteins, TGRLPs, atherosclerotic vascular disease, residue risk, very low-density lipoproteins, VLDLs, intermediate-density lipoproteins, IDLs, pathogenesis, atherosclerosis, hypertriglyceridemia, National Cholesterol Education Program Adult Treatment Panel III, NCEP ATP III, apolipoprotein B, apoB, vascular inflammation, hypertriglyceridemia, type 2 diabetes, VA Central California Health Care System, VACCHCS, International Classification of Diseases, Bachman Synchron LX 200 Analyzer, VA Northern California Institutional Review Board, McNemar's test
Legacy Keywords
diabetic dyslipidemia, low-density lipoprotein, LDL, metabolic derangements, type 2 diabetes, cardiovascular complications, cardiovascular disease, CVD, high-density lipoprotein, HDL, triglyceride, TG, Framingham heart, lipoprotein abnormalities, atherogenic LDL particle, TG-rich lipoproteins, TGRLPs, atherosclerotic vascular disease, residue risk, very low-density lipoproteins, VLDLs, intermediate-density lipoproteins, IDLs, pathogenesis, atherosclerosis, hypertriglyceridemia, National Cholesterol Education Program Adult Treatment Panel III, NCEP ATP III, apolipoprotein B, apoB, vascular inflammation, hypertriglyceridemia, type 2 diabetes, VA Central California Health Care System, VACCHCS, International Classification of Diseases, Bachman Synchron LX 200 Analyzer, VA Northern California Institutional Review Board, McNemar's test diabetic dyslipidemia, low-density lipoprotein, LDL, metabolic derangements, type 2 diabetes, cardiovascular complications, cardiovascular disease, CVD, high-density lipoprotein, HDL, triglyceride, TG, Framingham heart, lipoprotein abnormalities, atherogenic LDL particle, TG-rich lipoproteins, TGRLPs, atherosclerotic vascular disease, residue risk, very low-density lipoproteins, VLDLs, intermediate-density lipoproteins, IDLs, pathogenesis, atherosclerosis, hypertriglyceridemia, National Cholesterol Education Program Adult Treatment Panel III, NCEP ATP III, apolipoprotein B, apoB, vascular inflammation, hypertriglyceridemia, type 2 diabetes, VA Central California Health Care System, VACCHCS, International Classification of Diseases, Bachman Synchron LX 200 Analyzer, VA Northern California Institutional Review Board, McNemar's test
Sections
Clinical Review
Article Source

PURLs Copyright

Inside the Article

Article PDF Media